The effects of immunization in human immunodeficiency virus type 1 infection [1]

New England Journal of Medicine

Volumn 335, Issue 11, 1996, Pages 817-819

  Farber, C M ^a   Barath, A A ^a   Dieye, T ^a   Kroon, F P ^a   Van Furth, R ^a   Bruisten, S M ^a   Stanley, S K ^a   Ostrowski, M A ^a   Fauci, A S ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; LAMIVUDINE; PNEUMOCOCCUS VACCINE; POKEWEED MITOGEN; RITONAVIR; TETANUS TOXOID; TYPHOID VACCINE; VIRUS RNA; ZALCITABINE; ZIDOVUDINE; BACTERIAL VACCINE;

ADULT; APOPTOSIS; CLINICAL ARTICLE; COMPLICATION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOREACTIVITY; INFECTION RISK; LETTER; MALE; PRIORITY JOURNAL; SALMONELLOSIS; STREPTOCOCCUS INFECTION; VIRUS ACTIVATION; VIRUS EXPRESSION; VIRUS IMMUNITY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; NOTE; VIROLOGY;

APOPTOSIS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNIZATION, SECONDARY; TETANUS TOXOID; VIRUS ACTIVATION; BACTERIAL VACCINES; MALE; RNA, VIRAL;

EID: 0029838501     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199609123351111     Document Type: Letter

References (0)